🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Clinical efficacy and tolerability for allergen specific immunotherapy (AIT...
Status
Completed
Location
Karolinska University Hospital
Start Date
2023-02-01
Trial ID
NCT06085963
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability, and prel...
Status
Active Not Recruiting
Location
University of Alabama At Birmingham
Start Date
2021-02-23
Trial ID
NCT04279847
Treatments Being Tested
This phase I trial tests the safety, side effects, and best dose of ZEN0036...
Status
Recruiting
Location
Keck Medicine of USC Koreatown
Start Date
2023-08-10
Trial ID
NCT05372640
The goal of this study is to better understand how people predict the futur...
Status
Completed
Location
National University of Singapore
Start Date
2020-05-15
Trial ID
NCT04410692
Treatments Being Tested
This is a platform trial to conduct a series of randomized, double-blind, p...
Status
Completed
Location
University of Alabama at Birmingham School of Medicine - Infectious Disease
Start Date
2021-08-03
Trial ID
NCT04988035
Treatments Being Tested
The purpose of this study is to evaluate the long-term safety and the clini...
Status
Recruiting
Location
University of California LA
Start Date
2024-08-13
Trial ID
NCT06401356
Treatments Being Tested
Purpose of the study is the validation and cultual adaptation of the Turkis...
Status
Completed
Location
Prof Dr Cemil Tascioglu City Hospital
Start Date
2020-12-21
Trial ID
NCT04690166
Treatments Being Tested
Aim of this study is to use the major allergen 1 of birch-tree pollen (Bet ...
Status
Completed
Location
Medical University of Vienna
Start Date
2011-02
Trial ID
NCT02098551
Treatments Being Tested
To refine a remote behavioral exercise training intervention for testing in...
Status
Completed
Location
Virginia Commonwealth University
Start Date
2024-02-05
Trial ID
NCT06250751
Treatments Being Tested
This phase I/II trial tests the safety, side effects, and best dose of PLX2...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-01-13
Trial ID
NCT05677373